CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-22 | Lemaitre Dan Director | Sale | −1,097 | $85.02 | $93K | 0 |
| 2024-11-22 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −1,097 | 625 | ||
| 2024-11-21 | Davidar David D Director | Sale 10b5-1 | −13,234 | $85.00 | $1.1M | 523,041 |
| 2024-11-21 | Davidar David D Director | Sale 10b5-1 | −13,254 | $85.00 | $1.1M | 172,713 |
| 2024-11-21 | Lemaitre Dan Director | Option exercise | +13,278 | $65.05 | $864K | 13,278 |
| 2024-11-21 | Lemaitre Dan Director | Sale | −13,278 | $85.00 | $1.1M | 0 |
| 2024-11-21 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −13,278 | 1,722 | ||
| 2024-11-21 | Scavilla Daniel T President, CEO | Option exercise 10b5-1 | +50,000 | $43.77 | $2.2M | 50,000 |
| 2024-11-21 | Scavilla Daniel T President, CEO | Option exercise 10b5-1 | +80,000 | $43.58 | $3.5M | 130,000 |
| 2024-11-21 | Scavilla Daniel T President, CEO | Sale 10b5-1 | −130,000 | $85.00 | $11.1M | 0 |
| 2024-11-21 | Scavilla Daniel T President, CEO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −50,000 | 0 | ||
| 2024-11-21 | Scavilla Daniel T President, CEO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −80,000 | 0 | ||
| 2024-11-15 | Paul David C Executive Chairman | Option exercise | +26,042 | $24.10 | $628K | 26,042 |
| 2024-11-15 | Paul David C Executive Chairman | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −26,042 | 0 | ||
| 2024-11-06 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise 10b5-1 | +5,000 | $24.21 | $121K | 5,000 |
| 2024-11-06 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −2,500 | $80.02 | $200K | 2,500 |
| 2024-11-06 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −2,500 | $82.00 | $205K | 0 |
| 2024-11-06 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,000 | 2,500 | ||
| 2024-11-06 | Scavilla Daniel T President, CEO | Option exercise 10b5-1 | +30,000 | $26.27 | $788K | 30,000 |
| 2024-11-06 | Scavilla Daniel T President, CEO | Option exercise 10b5-1 | +30,000 | $43.77 | $1.3M | 60,000 |
Page 6 of 10 · 200 trades